Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis

Figure 2

Kaplan-Meier survival analysis of Aurora-A expression in NSCLC patients. (A) High expression of Aurora-A (Aur-A) was closely correlated with poor overall survival, (B) and progression-free survival. The median duration of overall survival for patients with high and low expression of Aurora-A was 27.25 vs. 72.2 months (p < 0.001) and 15.5 vs. 57.5 months (p < 0.001), respectively.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us